Scholars Central

Case reportPublished 2011

Prolonged Effect of Botulinum Toxin- A Treatment in Patients with Myasthenia Gravis

Authors: Vikesh Patel, John Elston, Raman Malhotra

Journal of Clinical and Experimental Ophthalmology

Volume 2 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: To report the unexpectedly prolonged effect of botulinum toxin A (BTX) injection in patients with myasthenia gravis. Methods: Retrospective review of presenting history, clinical findings and treatment of two cases. Results: Two patients with myasthenia gravis underwent a single BTX injections for gustatory epiphora (case 1) and hemifacial spasm (case 2). The effect of the treatment lasted 18 months and at least 8 months respectively. Conclusion: We report the prolonged effect of BTX in two patients with myasthenia gravis. To our knowledge, the prolonged and distant effect of BTX in myasthenia gravis has not been specifically addressed in the literature. We postulate that this prolonged effect may be due to the presence of autoantibodies in patients with myasthenia gravis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Experimental Ophthalmology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Vikesh Patel”
  • BylineArticles whose byline prints “John Elston”
  • BylineArticles whose byline prints “Raman Malhotra”